demonstrated that LGALS7 exerts anti-inflammatory effects by suppressing the MAPK pathway through downregulation of miR-146a (32); however, although our study confirmed its upregulated expression in BPH samples, the functional significance and underlying mechanisms in the context of BPH remain to be elucidated. Here, LGALS7 is linked to benign prostatic hyperplasia.